BRPI0417626A - derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica, composição farmacêutica, uso de um derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica - Google Patents

derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica, composição farmacêutica, uso de um derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica

Info

Publication number
BRPI0417626A
BRPI0417626A BRPI0417626-0A BRPI0417626A BRPI0417626A BR PI0417626 A BRPI0417626 A BR PI0417626A BR PI0417626 A BRPI0417626 A BR PI0417626A BR PI0417626 A BRPI0417626 A BR PI0417626A
Authority
BR
Brazil
Prior art keywords
indol
carbonyl
alkyl
pain
tricyclically
Prior art date
Application number
BRPI0417626-0A
Other languages
English (en)
Inventor
Julia Adam-Worrall
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BRPI0417626A publication Critical patent/BRPI0417626A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"DERIVADO DE 1-¢(INDOL-3-IL)CARBONIL!PIPERAZINA TRICìCLICA, COMPOSIçãO FARMACêUTICA, USO DE UM DERIVADO DE 1-¢(INDOL-3-IL)CARBONIL!PIPERAZINA TRICìCLICA". A invenção diz respeito a derivado de 1-¢(indol-3-il)carbonil!piperazina tricíclica tendo Fórmula Geral I Fórmula I em que X é CH~ 2~, O ou S; R representa 1 a 3 substituintes independentemente selecionados de H, alquila C~ 1-4~, alquilóxi C~ 1-4~ e halógeno; R~ 1~ é cicloalquila C~ 5-8~; R~ 2~ é H ou alquila C~ 1-4~; R~ 3~, R~ 3~<39>, R~ 4~, R~ 4~<39>, R~ 5~ , R~ 5~<39> e R~ 6~<39> são independentemente hidrogênio ou alquila C~ 1-4~, opcionalmente substituída por alquilóxi C~ 1-4~, OH ou halógeno; R~ 6~ é hidrogênio ou alquila C~ 1-4~, opcionalmente substituída por alquilóxi C~ 1-4~, OH ou halógeno; ou R~ 6~ forma, junto com R~ 7~, um anel heterocíclico saturado de 4 a 7 membros, opcionalmente contendo um outro heteroátomo selecionado de O e S; R~ 7~ forma, junto com R~ 6~, um anel heterocíclico saturado de 4 a 7 membros, opcionalmente contendo um outro heteroátomo selecionado de O e S; ou R~ 7~ é H, alquila C~ 1-4~ ou cicloalquila C~ 3-5~, os grupos alquila sendo opcionalmente substituídos por OH, halógeno ou alquilóxi C~ 1-4~; ou um seu sal farmaceuticamente aceitável. A invenção também diz respeito a composições farmacêuticas que compreendem os referidos derivados de 1-¢(indol-3-il)carbonil!piperazina tricíclica, e ao uso destes derivados no tratamento da dor, tal como a dor perioperatória, a dor crónica, a dor neuropática, a dor do câncer e a dor e a espasticidade associadas com a esclerose múltipla.
BRPI0417626-0A 2003-12-17 2004-12-13 derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica, composição farmacêutica, uso de um derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica BRPI0417626A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53052803P 2003-12-17 2003-12-17
EP03104768 2003-12-17
PCT/EP2004/053421 WO2005058327A1 (en) 2003-12-17 2004-12-13 Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists

Publications (1)

Publication Number Publication Date
BRPI0417626A true BRPI0417626A (pt) 2007-03-27

Family

ID=34702353

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417626-0A BRPI0417626A (pt) 2003-12-17 2004-12-13 derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica, composição farmacêutica, uso de um derivado de 1-[(indol-3-il) carbonil] piperazina tricìclica

Country Status (11)

Country Link
US (1) US7772227B2 (pt)
EP (1) EP1696930B1 (pt)
AT (1) ATE359078T1 (pt)
AU (1) AU2004298782B2 (pt)
BR (1) BRPI0417626A (pt)
CA (1) CA2549147C (pt)
DE (1) DE602004005893T2 (pt)
ES (1) ES2284076T3 (pt)
IL (1) IL175675A0 (pt)
MX (1) MXPA06006928A (pt)
WO (1) WO2005058327A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
CN100448849C (zh) * 2006-02-02 2009-01-07 深圳市天和医药科技开发有限公司 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
US9353933B2 (en) * 2009-09-25 2016-05-31 Cree, Inc. Lighting device with position-retaining element
US9216998B2 (en) * 2012-02-15 2015-12-22 Janssen Pharmaceutica Nv Tricyclic indole derivatives useful endothelial lipase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939138A (en) 1988-12-29 1990-07-03 Sterling Drug Inc. 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines
ZA902794B (en) 1989-04-18 1991-04-24 Duphar Int Res New 3-n substituted carbamoyl-indole derivatives
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
CA2340445A1 (en) 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
EP1243268A4 (en) 1999-12-14 2003-05-21 Nippon Shinyaku Co Ltd MEDICINAL COMPOSITION
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
TW200402417A (en) * 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
DE602004005893D1 (de) 2007-05-24
US20070088025A1 (en) 2007-04-19
EP1696930A1 (en) 2006-09-06
DE602004005893T2 (de) 2007-09-06
ATE359078T1 (de) 2007-05-15
CA2549147C (en) 2012-04-10
EP1696930B1 (en) 2007-04-11
WO2005058327A1 (en) 2005-06-30
US7772227B2 (en) 2010-08-10
AU2004298782A1 (en) 2005-06-30
IL175675A0 (en) 2006-09-05
AU2004298782B2 (en) 2010-06-17
MXPA06006928A (es) 2006-09-04
ES2284076T3 (es) 2007-11-01
CA2549147A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
CY1116183T1 (el) Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
ATE437872T1 (de) Proteinkinaseinhibitoren
ATE369370T1 (de) Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren
TW200626579A (en) Inhibitors of the interaction between MDM2 and p53
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
SE0300119D0 (sv) Novel compounds
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
TW200612936A (en) Indole derivatives
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
IL175675A0 (en) Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
PL361282A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
HUP0303279A2 (hu) Indolo-pirrolo-karbazolok cukorszármazékai, mint topoizomeráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
MXPA05010651A (es) Compuestos de pirazol.
SE0303090D0 (sv) Novel compounds
ATE384708T1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren
MY140653A (en) Substituted diketopiperazines and their use as oxytocyn antagonists
MXPA05010650A (es) Pirazoles sustituidos.
DE602004016177D1 (de) Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten
MXPA05012096A (es) Derivados de amina ciclica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
RS20060502A (en) (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
SE0403118D0 (sv) New compounds 2

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.